← FDA DRUG APPROVALS

FDA ANDA · ANDA074114

DOBUTAMINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA074114
TYPE
ANDA
ORIGINAL APPROVAL
1993-11-30
LATEST ACTION
1999-02-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DOBUTAMINE HYDROCHLORIDEDiscontinued
DOBUTAMINE HYDROCHLORIDE EQ 12.5MG BASE/ML · INJECTABLE · INJECTION

Approval history

1999-02-19Manufacturing (CMC) · Supplement 5AP
1999-02-02Manufacturing (CMC) · Supplement 4AP
1998-08-28Manufacturing (CMC) · Supplement 3AP
1996-12-04Manufacturing (CMC) · Supplement 2AP
1996-07-31Labeling · Supplement 1AP
1993-11-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →